The latest update on Friday morning shows Ligand Pharmaceuticals shares down by 0.0%, trading at $198.41. At this price, Espinoza’s 2,381 shares are worth
Latest News
Insider Decision: David Fisher Exercises Options At Enova International For $2.08M
What Happened: A notable Form 4 filing on Thursday with the U.S. Securities and Exchange Commission revealed that Fisher, Chief Executive Officer at Enova
9 states tax Social Security benefits. Is Florida one of them?
More than 5 million people in Florida claim Social Security benefits. Are those benefits taxable? There are in nine states, but what about Florida?
Stock market today: Dow rises but Nike plunges on earnings (live coverage)
Nike stock plunged more than 11% despite topping estimates on results for 2026’s fiscal second quarter, as lower sales from China continue to dent
NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Look to Stretch Higher
US equity indices show tentative recovery attempts, but holiday-thinned liquidity is limiting momentum. Key technical levels remain in focus across the NASDAQ 100, S&P
What will the stock market do in 2026? Here’s why AI will dominate
Even though many Americans remain glum about the economy and the state of the country, there may be good news in financial markets next
Stock market today: Dow, S&P 500, Nasdaq rise with Wall Street set to wrap up latest volatile week
US stocks edged higher on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street
American Tungsten Grants Incentive Stock Options
American Tungsten Corp. (CSE: TUNG) (OTCQB: TUNGF) (FSE: RK90) (“American Tungsten” or the “Company”) announced that it has …
Why This AI Stock Could Outperform Nvidia Over the Next 5 Years
Keithen Drury, The Motley Fool December 19, 2025 at 7:20 AM Key Points Nvidia (NASDAQ: NVDA) has led the artificial intelligence (AI) investing sector
Buffett Leaving Berkshire Creates a ‘Vacuum Risk’ and a $381 Billion Question
Watch the Video I started the discussion by acknowledging something that feels almost unnatural for long-time Berkshire watchers. Warren Buffett is struggling, at least